Kusajili – Clinical trials directory

Result of your search per specialist: Novartis Pharma S.A.S

Woman and Man Max 99 years
Novartis Pharma S.A.S Update Il y a 4 ans

A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA) This study is designed to confirm the efficacy, the tolerability, the patient compliance and the caregiver satisfaction with rivastigmine target patch size 10 cm^2 in patients with probabl...

Country None
organs None
Specialty None

Closed trial

More information